FMC Corp (NYSE:FMC)
$ 10.91 +0.020 (+0.18%) Market Cap: 1.37 Bil Enterprise Value: 5.54 Bil PE Ratio: 0 PB Ratio: 0.75 GF Score: 43/100

Q1 2026 FMC Corp Earnings Call Transcript

Apr 30, 2026 / 01:00PM GMT
Release Date Price: $15.38 (+4.98%)

Key Points

Positve
  • FMC Corp (FMC) exceeded the midpoint of their guidance for the first quarter of 2026.
  • The company is targeting approximately $1 billion in debt reduction during 2026, with significant progress in selling their India commercial business.
  • Sales of new active ingredients, including Isoflex Active, Fluindapyr, and Dodhylex Active, doubled year over year in the first quarter.
  • FMC Corp (FMC) received regulatory approval for Isoflex Active in the EU, marking the first new herbicide approval in the region since 2019.
  • The company is seeing positive signals in LatAm, with a significant number of orders already in hand for the second half of the year.
Negative
  • First-quarter sales were 4% lower than the prior year, with a 6% decline in prices driven by lower sales to diamide partners.
  • Adjusted EBITDA for the second quarter is expected to decline by 32% at the midpoint compared to the prior year.
  • Full-year 2026 sales are projected to decline by 5% at the midpoint, with a 17% decline in EBITDA.
  • The company is facing increased uncertainty related to tariffs and the conflict in Iran, impacting energy, transportation, and petrochemical costs.
  • Free cash flow for 2026 is expected to range from negative $65 million to positive $65 million, reflecting challenges in cash generation.
Operator

Ladies and gentlemen, thank you for joining us and welcome to the first-quarter 2026 earnings call for FMC Corporation. This event is being recorded. (Operator Instructions)

I will now hand the conference over to Mr. Curt Brooks, Director of Investor Relations for FMC Corporation. Please go ahead.

Curt Brooks
FMC Corp - Director of Investor Relations

Good morning, and welcome to FMC Corporation's 2026 first-quarter earnings call. Today's prepared remarks will be provided by Pierre Brondeau, Chairman, Chief Executive Officer, and President; and Andrew Sandifer, Executive Vice President and Chief Financial Officer. After prepared comments, we will take questions. Our earnings release and today's slide presentation are available on the FMC Investor Relations website, and the prepared remarks from today's discussion will be made available after the call.

Let me remind you that today's presentation and discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including but

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot